Paper · 8790396

Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan.

Pluschke G and 7 others. Proc Natl Acad Sci U S A, 1996. Cited by 146 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan. Papers, record 8790396. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8790396

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan.; PubMed
Journal: Proc Natl Acad Sci U S A; PubMed
Year: 1996; PubMed
Publication types: Journal Article, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/8790396/; PubMed
DOI: https://doi.org/10.1073/pnas.93.18.9710; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC38494/; PubMed
The journal: https://conductscience.org/library/journal-index/7505876; PubMed
Citations, by iCite: 146; iCite
Relative citation ratio, by iCite: 3.11; iCite
Revised in PubMed: 2026-01-28; PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Pluschke G	G
2	Vanek M	M
3	Evans A	A
4	Dittmar T	T
5	Schmid P	P
6	Itin P	P
7	Filardo EJ	E J
8	Reisfeld RA	R A

Source PubMed

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Chondroitin Sulfate Proteoglycans	Major topic
Melanoma	Major topic
Membrane Proteins	Major topic
Skin Neoplasms	Major topic
Adult
Amino Acid Sequence
Animals
Base Sequence
Blotting, Northern
Cell Line
Cloning, Molecular
DNA, Complementary
Humans
In Situ Hybridization
Molecular Sequence Data
Open Reading Frames
Polymerase Chain Reaction
RNA, Messenger
Rats
Chondroitin Sulfate Proteoglycan 4

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by
CA42508	NCI NIH HHS	United States	R35CA042508	PubMed and NIH

Source NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	6,208,137	Serological and biochemical analyses of monoclonal antibodies to human melanoma-associated antigens.	Hybridoma	1982	https://conductscience.org/library/papers/6208137	PubMed
2	6,208,129	Immunochemical and biosynthetic analysis of monoclonal antibody-defined melanoma-associated antigen.	Hybridoma	1982	https://conductscience.org/library/papers/6208129	PubMed
3	6,333,489	Monoclonal antibody therapy of malignant melanoma: in vivo localization in cutaneous metastasis after intravenous administration.	J Clin Oncol	1984	https://conductscience.org/library/papers/6333489	PubMed
4	3,633,135	Human melanoma proteoglycan: expression in hybrids controlled by intrinsic and extrinsic signals.	Science	1986	https://conductscience.org/library/papers/3633135	PubMed
5	4,522,461	Evaluation of C3 receptors on lymphoid cells with different complement sources.	J Immunol	1974	https://conductscience.org/library/papers/4522461	PubMed
6	4,151,463	Clonal cell lines from the rat central nervous system.	Nature	1974	https://conductscience.org/library/papers/4151463	PubMed
7	4,850,204	A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.	Eur J Biochem	1974	https://conductscience.org/library/papers/4850204	PubMed
8	271,968	DNA sequencing with chain-terminating inhibitors.	Proc Natl Acad Sci U S A	1977	https://conductscience.org/library/papers/271968	PubMed
9	7,451,981	Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera.	J Immunol	1981	https://conductscience.org/library/papers/7451981	PubMed
10	7,023,366	Synthesis and processing of asparagine-linked oligosaccharides.	Annu Rev Biochem	1981	https://conductscience.org/library/papers/7023366	PubMed

1 to 10 of 34

See all 34 references

Cited by56

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.

PMID	Title	Journal	Year	In Papers	Source
40,720,084	Targeting CSPG4 enhances the anti-tumor activity of CAR-NK cells for glioblastoma.	Cell Oncol (Dordr)	2025	https://conductscience.org/library/papers/40720084	PubMed
40,650,861	Glial Cells in Alzheimer's Disease: Pathogenic Mechanisms and Therapeutic Frontiers.	J Mol Neurosci	2025	https://conductscience.org/library/papers/40650861	PubMed
40,201,239	Computational analysis of the structural-functional dynamics of a Co-receptor proteoglycan.	Front Mol Biosci	2025	https://conductscience.org/library/papers/40201239	PubMed
39,863,819	CSPG4 overexpression implicates higher risks of recurrence and tumorigenesis after surgical intervention of vocal fold Leukoplakia.	Eur Arch Otorhinolaryngol	2025	https://conductscience.org/library/papers/39863819	PubMed
39,136,008	Nerve-Glial antigen 2: unmasking the enigmatic cellular identity in the central nervous system.	Front Immunol	2024	https://conductscience.org/library/papers/39136008	PubMed
37,559,576	Immunohistochemical detection of the chondroitin sulfate proteoglycan 4 protein in primary and metastatic melanoma.	Oncol Lett	2023	https://conductscience.org/library/papers/37559576	PubMed
37,404,752	CAR-NK cell therapy for glioblastoma: what to do next?	Front Oncol	2023	https://conductscience.org/library/papers/37404752	PubMed
36,428,658	Chondroitin Sulfate Proteoglycan 4 as a Marker for Aggressive Squamous Cell Carcinoma.	Cancers (Basel)	2022	https://conductscience.org/library/papers/36428658	PubMed
35,280,756	Co-Expression and Combined Prognostic Value of CSPG4 and PDL1 in TP53-Aberrant Triple-Negative Breast Cancer.	Front Oncol	2022	https://conductscience.org/library/papers/35280756	PubMed
34,440,182	Antibody Conjugates for Sarcoma Therapy: How Far along Are We?	Biomedicines	2021	https://conductscience.org/library/papers/34440182	PubMed

1 to 10 of 56

See all 56 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes
CSPG4	1,464	Swiss-Prot's references	https://conductscience.org/library/genes/1464

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bank	Accession
GENBANK	X96753

Source GENBANK

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8790396

GET https://conductscience.org/api/papers/v1/8790396/references?page=2

API reference For AI assistants